Skip to main content

. 2024 Feb 17;24:76. doi: 10.1186/s12935-024-03243-2

Correction: A novel mechanism by which ACTA2-AS1 promotes cervical cancer progression: acting as a ceRNA of miR-143-3p to regulate SMAD3 expression

Lingli Luo ¹, Min Wang ^1,^✉, Xianping Li ¹, Can Luo ¹, Shan Tan ¹, Sheng Yin ¹, Lei Liu ¹, Xiaolin Zhu ¹

PMCID: PMC10873971 PMID: 38368331

Correction: Cancer Cell Int (2020) 20:372 10.1186/s12935-020-01471-w

In this article [1], there was an error in Fig. 6. The corrected Fig. 6 is given below.

Fig. 6 — The efect of ACTA2-AS1/miR-143-3p/SMAD3 axis on progression of CC. a The knock-down ability of si-SMAD3 in HeLa and SiHa cells was confrmed by qRT-PCR. b The over-expression ability of pcDNA-ACTA2-AS1 was confrmed by qRT-PCR. c Cell viability was detected by CCK8 assay after transfecting with si-SMAD3 and co-transfecting with pcDNA‐ACTA2‐AS1 or miR-143-3p inhibitor. d The migration ability of transfected cells was analyzed by transwell assay. e Apoptosis condition of transfected cells was analyzed by fow cytometry analysis. ** P<0.05

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reference

1.Luo L, Wang M, Li X, Luo C, Tan S, Yin S, Liu L, Zhu X. A novel mechanism by which ACTA2-AS1 promotes cervical cancer progression: acting as a ceRNA of miR-143-3p to regulate SMAD3 expression. Cancer Cell Int. 2020;20:372. doi: 10.1186/s12935-020-01471-w. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES